3C
MYOK

361 Capital’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

361 Capital’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-44,018
Closed -$2.15M – 428
2018
Q4 		$2.15M Buy
+44,018
New +$2.42M 0.44% 112

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

361 Capital's MYOK Position: Q1 2019 in Review

361 Capital sold out of MyoKardia, Inc. Common Stock (MYOK) in Q1 2019, closing a stake of 44,018 shares — an estimated $2.15M sold.

361 Capital first reported a position in MYOK in Q4 2018 and held it in 1 quarter. The position peaked at $2.15M in Q4 2018. 169 funds tracked by Wall St. Rank hold MYOK as of Q1 2019.

  • 361 Capital reported no remaining MyoKardia, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • 361 Capital sold 44,018 MyoKardia, Inc. Common Stock shares in Q1 2019, an estimated $2.15M.
  • 361 Capital first reported a position in MyoKardia, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • 361 Capital's MyoKardia, Inc. Common Stock position peaked at $2.15M in Q4 2018.
  • 169 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q1 2019.

Based on 361 Capital's 13F filing for Q1 2019, filed 7 May 2019.